Growth Metrics

Incyte (INCY) EBIT Margin Growth (5y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Incyte 19.28 Bn 15.27 Bn 1.17 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 732.00
Dec 31, 2025 149.00
Sep 30, 2025 3,161.00
Jun 30, 2025 1,009.00
Mar 31, 2025 13,628.00
Dec 31, 2024 918.00
Sep 30, 2024 -1,151.00
Jun 30, 2024 -6,442.00
Mar 31, 2024 -445.00
Dec 31, 2023 2,284.00
Sep 30, 2023 1,644.00
Jun 30, 2023 434.00
Mar 31, 2023 2,062.00
Dec 31, 2022 719.00
Sep 30, 2022 1,287.00
Jun 30, 2022 2,569.00
Mar 31, 2022 5,059.00
Dec 31, 2021 3,284.00
Sep 30, 2021 2,068.00
Jun 30, 2021 185.00
Mar 31, 2021 266.00
Dec 31, 2020 1,380.00
Sep 30, 2020 91.00
Jun 30, 2020 3,808.00
Mar 31, 2020 -11,244.00
Dec 31, 2019 3,707.00
Sep 30, 2019 -1,095.00
Jun 30, 2019 4,491.00
Mar 31, 2019 4,042.00
Dec 31, 2018 2,555.00
Sep 30, 2018 2,241.00
Jun 30, 2018 -107.00
Mar 31, 2018 -1,179.00
Dec 31, 2017 -1,162.00
Sep 30, 2017 2,070.00
Jun 30, 2017 -1,536.00
Mar 31, 2017 5,980.00
Dec 31, 2016 13,278.00
Sep 30, 2016 25,916.00
Jun 30, 2016 26,267.00
Mar 31, 2016 6,317.00
Dec 31, 2015 -1,293.00
Sep 30, 2015 13,067.00
Jun 30, 2015 -3,187.00
Mar 31, 2015 11,035.00